AKTX

AKARI THERAPEUTICS PLC

AKTX·00972G108·US·ADR·Healthcare - Biotechnology

AKTX (AKARI THERAPEUTICS PLC) is held by 4 institutional investors as of Q2 2026. Largest holders: Cresset Asset Management, LLC ($210,647), JANE STREET GROUP, LLC ($158,418), HRT FINANCIAL LP ($140,000). Net institutional sentiment: Bullish.

4
Holders
(2 Elite)
$509,137
Total Value
75% (4)
Consensus
3 buying - 1 selling
13F: Insider & Congress: Updated regularly
AKTX

Smart Money Verdict

View all
Loading verdict
Held by 4 funds
2 elite

Who's Trading

Source dates: Price Oct 16, 2026 · Insiders Oct 16, 2026 · Activists none · Congress none

InsiderGAGaslightwala AbizerExercise 19K shOct 14, 2026
InsiderPIPatel Sandip IExercise 6K shOct 14, 2026
InsiderBBBazemore Robert BExercise 3K shOct 14, 2026
Checking access…

Top Holders

Checking access…
Action
Unchanged
20,561$210,6470.0%+3456.52%
0
New
15,463$158,4180.0%-20.16%
34
New
13,745$140,0000.0%-20.16%
31
New
7$720.0%-20.16%
17
Exited
0(-100.0%)$50.0%+4354.35%
0
AKTXAKTXAKARI THERAPEUTICS PLC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used